Medicare Enrolled
Dr. Asad Dean, MD
Medical Oncology · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dean from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dean?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dean
Dr. Asad Dean is a medical oncology specialist in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dean performed 40,161 Medicare services across 2,381 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dean received a total of $1,097,171 from 61 pharmaceutical and/or device companies across 1851 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dean is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in TX
$1,097,171 industry payments
Medicare Practice Summary
Medicare Utilization ↗40,161
Medicare services
Top 23% in TX for medical oncology
2,381
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,008 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 8,000 | $43 | $137 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
6,300 | $0 | $13 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,200 | $0 | $2 |
| Paclitaxel chemotherapy injection | 5,874 | $0 | $8 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,100 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 1,320 | $19 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,126 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
701 | $8 | $20 |
| Injection, granisetron hydrochloride, 100 mcg | 660 | $0 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
633 | $10 | $64 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
626 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
595 | $91 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 520 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
183 | $102 | $707 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
175 | $7 | $431 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
173 | $12 | $108 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
149 | $2 | $300 |
| PSA test (prostate cancer screening) | 123 | $18 | $94 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
115 | $57 | $211 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
99 | $48 | $313 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
97 | $25 | $143 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
94 | $23 | $157 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
73 | $16 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
72 | $11 | $96 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
71 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
69 | $6 | $34 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
67 | $13 | $60 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
67 | $50 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
67 | $1 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 63 | $137 | $3,675 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
60 | $17 | $60 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
58 | $1,163 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 57 | $90 | $657 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 53 | $20 | $128 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
53 | $1 | $8 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
49 | $6 | $31 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
49 | $35 | $143 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
48 | $22 | $161 |
| Iron level test | 47 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
47 | $9 | $35 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
46 | $10 | $75 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $26 | $145 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
36 | $2 | $19 |
| New patient office visit, complex (60-74 min) | 29 | $157 | $709 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $93 | $357 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
20 | $1 | $19 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
18 | $19 | $99 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
13 | $8 | $49 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
89.6% medium
8.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,097,171
Total received (2018-2024)
Avg $156,739/year across 7 years
Top 2% in TX for medical oncology
61
Companies
1,851
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,045,011 (95.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,812 (4.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,347 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$112,028
2023
$243,526
2022
$203,599
2021
$145,738
2020
$84,481
2019
$186,838
2018
$120,960
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Pharmacyclics LLC, An AbbVie Company
$276,594
Janssen Biotech, Inc.
$232,684
Lilly USA, LLC
$186,130
Pharmacyclics LLC, an AbbVie Company
$113,125
Verastem, Inc.
$85,133
AVEO Pharmaceuticals, Inc.
$55,223
Seagen Inc.
$50,276
Aveo Pharmaceuticals, Inc.
$34,525
Astellas Pharma US Inc
$14,849
TG THERAPEUTICS, INC.
$12,223
Secura Bio, Inc.
$9,341
Genentech USA, Inc.
$6,442
Seattle Genetics, Inc.
$4,614
AbbVie, Inc.
$4,424
Exelixis Inc.
$3,612
AstraZeneca Pharmaceuticals LP
$842
Janssen Scientific Affairs, LLC
$807
GENZYME CORPORATION
$656
Novocure Inc.
$553
ABBVIE INC.
$498
PFIZER INC.
$416
Ipsen Biopharmaceuticals, Inc
$368
Astellas Pharma Global Development
$334
Genmab U.S., Inc.
$302
Adaptive Biotechnologies Corporation
$281
Incyte Corporation
$263
Novartis Pharmaceuticals Corporation
$250
Kite Pharma, Inc.
$162
Onkos Surgical, Inc.
$153
Puma Biotechnology, Inc.
$152
Celgene Corporation
$151
ADC Therapeutics America, Inc.
$137
SOBI, INC
$136
E.R. Squibb & Sons, L.L.C.
$136
Sirtex Medical Inc
$127
Myriad Genetic Laboratories, Inc.
$121
TG Therapeutics, Inc.
$117
SECURA BIO, INC.
$98
EMD Serono, Inc.
$78
BeiGene USA, Inc.
$73
Karyopharm Therapeutics Inc.
$71
Gilead Sciences, Inc.
$67
Rigel Pharmaceuticals, Inc.
$66
GlaxoSmithKline, LLC.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$59
SANOFI-AVENTIS U.S. LLC
$55
Merck Sharp & Dohme Corporation
$55
Alexion Pharmaceuticals, Inc.
$48
Epizyme, Inc.,
$45
Stemline Therapeutics Inc.
$37
Pharmacosmos Therapeutics Inc.
$34
Mirati Therapeutics, Inc.
$20
Merck Sharp & Dohme LLC
$19
Tempus AI, Inc
$18
Tactile Systems Technology Inc
$18
Amgen Inc.
$17
Iovance Biotherapeutics, Inc.
$17
Alnylam Pharmaceuticals Inc.
$17
Teva Pharmaceuticals USA, Inc.
$14
Bio Products Laboratory USA, Inc.
$14
Array BioPharma Inc.
$14
Top 3 companies account for 63.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · Amtagvi · BALVERSA · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CALQUENCE · COPIKTRA · Cabometyx · Copiktra · DARZALEX · DAURISMO · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Epkinly · Erleada · FARYDAK · FOTIVDA · Fabhalta · Farydak · Flexitouch Plus · Gammaplex · ICLUSIG · IMBRUVICA · INLYTA · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUPRON DEPOT · MEKINIST · MONJUVI · Monoferric · Nerlynx · NovoTTF-100L · OJJAARA · ONIVYDE · ONPATTRO · OPDIVO · Oncology · Optune · Orserdu · PADCEV · PROLARIS · PROMACTA · Padcev · REBLOZYL · RETEVMO · RYBREVANT · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · TALZENNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · XGEVA · XPOVIO · XTANDI · Xtandi · Yescarta · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for medical oncology in TX.
Equivalent to $2,732 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
26
Per 100K population
1.2
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dean is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), with speaking/promotional industry engagement in the top 2% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dean experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Dean performed 8,000 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dean receive payments from pharmaceutical companies?
Yes. Dr. Dean received a total of $1,097,171 from 61 companies across 1,851 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dean's costs compare to other medical oncologists in Fort Worth?
Dr. Dean's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dean) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fort Worth
Browse medical oncologists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Pharmacyclics LLC, An AbbVie Company Payments to Doctors
See all physicians who received payments from Pharmacyclics LLC, An AbbVie Company.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology